By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – HealthLinx separately announced this month a collaboration with the Garvan Institute of Medical Research to assess HealthLinx's IP for prostate cancer, and the appointment of CPC Clinical Research to aid it in obtaining approval from US regulators for its ovarian cancer test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.